CA-ONE-MIND
One Mind at Work, a leading mental health non-profit, Columbia University Mental Health + Work Design Lab, and corporate ethical standards measurement company Ethisphere, have formed a partnership to develop the Mental Health at Work Index™. The Index includes a standardized assessment of organizational programs and practices that support workforce mental health and an advice library that provides recommendations and resources to guide data-driven strategic improvement and innovations.
Accelerated by the COVID pandemic, around the world, the case for attending to mental health at work has never been greater. Research from the World Health Organization shows that 15 percent of working adults are affected by a mental health condition. The majority of workers expect their employers to support their mental health, and nearly all believe that employers could take actions that would make a real difference.
Recognizing the importance of providing a standardized tool to help organizations of all sizes and industries globally invest in sustainable and best-practice workplace mental health programs, a Founding Corporate Council of nine organizations have come together to help drive the development and adoption of the Mental Health at Work Index™. These founding members contribute their expertise and perspectives to ensure the practical value of the Index.
The founding members include:
- AXA, Asia & Africa, Founding Principal Partner
- Aon
- Bank of America
- Business Group on Health
- HCA Healthcare
- Jardine Matheson, MINDSET Care Limited (Singapore) and MINDSET Limited (Hong Kong)
- LifeWorks
- Prudential
- URAC
The Mental Health at Work Index™ will launch in early 2023 after the current beta testing phase is complete.
By completing The Mental Health at Work Index™, organizations can benchmark their programs and services, and use the personalized reports generated to help develop high-quality services and offerings that will translate into real impact.
Aligned with global guidance and standards, including International Organization for Standardization, Sustainability Accounting Standards Board, and the recently released World Health Organization guidelines, the Index guides leaders through an algorithm-driven library of resources and practical recommendations. These resources and evidence-based recommendations will provide business leaders with real data to inform strategic decision making about what has impact when it comes to mental health programs.
The Mental Health at Work Index “Three Ps Framework” assesses workforce mental health programs across the continuum of Protection, Promotion and Provision of care. The assessment dives deep into 10 organizational categories: mental health strategy, leadership, workforce engagement, communication, organizational culture, mental health training, work environment, mental health benefits, employment practices and monitoring and reporting.
Christina McCarthy, Executive Director of One Mind at Work, said, “The pandemic has highlighted the need for companies to invest in sustainable mental health strategies to support their employees. While approaches vary across different companies, the evidenced-based and technology-enabled Mental Health at Work Index sets a common standard, with best practice guidelines on the evaluation of workplace mental health initiatives that are vital in ensuring their success. It also helps equip companies with easy-to-access resources and practical recommendations to support mental health in the workplace in impactful, measurable ways.”
Dr. Kathleen M. Pike, Director of the Columbia University Mental Health + Work Design Lab said, “The data don’t lie. Mental health is impacting the workforce at every company and ignoring it is not an option. The Mental Health at Work Index is designed to empower leaders who recognize the needs of their workforce and are ready to step up on this critical issue. By partnering with One Mind and Ethisphere, we are tapping into a reservoir of expertise, creating evidence-based solutions to help leaders drive data-informed strategies that translate into better health and greater productivity for workers, while also shoring up recruitment and retention of talent.”
Craig Moss, EVP-Measurement of Ethisphere, said, “It is exciting to partner with Columbia University Mental Health + Work Design Lab and One Mind to bring our expertise in developing maturity assessments to the critical topic of mental health practices. Ultimately, companies need to create a culture that supports the mental health of their workforce. The Mental Health at Work Index will define what good looks like, create a maturity ladder and provide resources to make the improvement journey faster and more efficient. Under the leadership of AXA, the Founding Corporate Council has been a tremendous resource in helping us understand current practices, challenges, and opportunities for improvement.”
Gordon Watson, CEO of AXA Asia and Africa, said, “We are proud to be the founding principal partner of this pioneering Mental Health at Work Index, taking a leading role in collaborating with One Mind, Columbia University Mental Health + Work Design Lab, and Ethisphere. While companies are increasingly stepping up with expanded benefits to support the mental well-being of their people, more is needed when it comes to benchmarking progress made. The Index will address this critical gap by establishing a guided path for companies to achieve measurable progress in line with global standards. This is essential as companies continue to invest in and refine their mental health initiatives and ultimately deliver better mental health outcomes for employees.”
For more on the Mental Health at Work Index, visit mentalhealthindex.org, or email info@mentalhealthindex.org.
About One Mind and One Mind at Work
One Mind is a leading mental health non-profit that heals lives through science and advocacy. Around our collective vision of “Accelerating Brain Health for All”, One Mind is advancing a three-pronged program strategy of accelerating discoveries, scaling implementation, and transforming societal culture. Together, we are creating a world where all individuals facing brain health challenges can build healthy, productive lives. www.onemind.org
As an arm of One Mind, One Mind at Work is a global coalition of organizations committed to the development and implementation of a gold standard for workplace mental health and well-being. With most of the world’s population spending one-third of their adult lives at work, employers have a tremendous opportunity to improve quality of life for all people and play a critical role in driving mental health solutions. Leaving mental health needs unaddressed has costly results like higher absenteeism, increased liability, and lost productivity. One Mind at Work believes that a committed group of CEOs can transform the way we view and approach mental health, brain fitness, and well-being in the workplace. Today, there are nearly 150 One Mind at Work member organizations.
About The Columbia University Mental Health + Work Design Lab
The Mental Health + Work Design Lab, led by Dr. Kathleen M. Pike, provides thought leadership, content expertise, scientific research, and strategic guidance on advancing mental health at work. The Mental Health + Work Design Lab has a long history of collaborating closely with a wide range of organizations – both non-profit and for-profit, around the world – to address mental health at work. As part of the Columbia-World Health Organization Center for Global Mental Health, Dr. Pike and colleagues contributed scientific analysis and reporting to the forthcoming WHO Guidelines for Mental Health at Work. Providing targeted research reports, analytic models, survey instruments, and training programs, The Mental Health + Work Design Lab is committed to translating science into practice to improve mental health at work. The Mental Health + Work Design Lab streamlines the process of working with Columbia’s world-renowned researchers to bring scientific rigor to the pursuit of workforce mental health solutions.
About Ethisphere
Ethisphere is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust, and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character. Ethisphere honors superior achievement through its World’s Most Ethical Companies® recognition program, provides a community of industry experts with the Business Ethics Leadership Alliance (BELA), and showcases trends and best practices in ethics with Ethisphere Magazine. Ethisphere also helps to advance business performance through data-driven assessments, benchmarking, and guidance. For more information, visit https://ethisphere.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005194/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom